AI assistant
Sending…
IONIS PHARMACEUTICALS INC — Director's Dealing 2011
Dec 20, 2011
30591_dirs_2011-12-20_5a480347-9594-460e-ab23-8536d63f9033.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ISIS PHARMACEUTICALS INC (ISIS)
CIK: 0000874015
Period of Report: 2011-12-16
Reporting Person: CROOKE STANLEY T (Director, Chairman, President, CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-12-16 | Common Stock | M | 15000 | $5.80 | Acquired | 15000 | Direct |
| 2011-12-16 | Common Stock | S | 15000 | $6.79 | Disposed | 0 | Direct |
| 2011-12-16 | Common Stock | M | 1500 | $5.80 | Acquired | 1500 | Indirect |
| 2011-12-16 | Common Stock | S | 1500 | $6.79 | Disposed | 0 | Indirect |
| 2011-12-19 | Common Stock | M | 1822 | $5.80 | Acquired | 1822 | Direct |
| 2011-12-19 | Common Stock | S | 1822 | $6.90 | Disposed | 0 | Direct |
| 2011-12-19 | Common Stock | M | 15178 | $5.80 | Acquired | 15178 | Direct |
| 2011-12-19 | Common Stock | S | 15178 | $6.82 | Disposed | 0 | Direct |
| 2011-12-19 | Common Stock | M | 118 | $5.80 | Acquired | 118 | Indirect |
| 2011-12-19 | Common Stock | S | 118 | $6.90 | Disposed | 0 | Indirect |
| 2011-12-19 | Common Stock | M | 982 | $5.80 | Acquired | 982 | Indirect |
| 2011-12-19 | Common Stock | S | 982 | $6.82 | Disposed | 0 | Indirect |
| 2011-12-20 | Common Stock | M | 22000 | $5.80 | Acquired | 22000 | Direct |
| 2011-12-20 | Common Stock | S | 22000 | $6.82 | Disposed | 0 | Direct |
| 2011-12-20 | Common Stock | M | 5000 | $5.80 | Acquired | 5000 | Direct |
| 2011-12-20 | Common Stock | S | 5000 | $6.92 | Disposed | 0 | Direct |
| 2011-12-20 | Common Stock | M | 300 | $5.80 | Acquired | 300 | Indirect |
| 2011-12-20 | Common Stock | S | 300 | $6.92 | Disposed | 0 | Indirect |
| 2011-12-20 | Common Stock | M | 1400 | $5.80 | Acquired | 1400 | Indirect |
| 2011-12-20 | Common Stock | S | 1400 | $6.82 | Disposed | 0 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-12-16 | Employee Stock Option (right to buy) | $5.80 | M | 15000 | Disposed | 2012-01-02 | Common Stock (15000) | Direct |
| 2011-12-16 | Employee Stock Option (right to buy) | $5.80 | M | 1500 | Disposed | 2012-01-02 | Common Stock (1500) | Indirect |
| 2011-12-19 | Employee Stock Option (right to buy) | $5.80 | M | 17000 | Disposed | 2012-01-02 | Common Stock (17000) | Direct |
| 2011-12-19 | Employee Stock Option (right to buy) | $5.80 | M | 1100 | Disposed | 2012-01-02 | Common Stock (1100) | Indirect |
| 2011-12-20 | Employee Stock Option (right to buy) | $5.80 | M | 27000 | Disposed | 2012-01-02 | Common Stock (27000) | Direct |
| 2011-12-20 | Employee Stock Option (right to buy) | $5.80 | M | 1700 | Disposed | 2012-01-02 | Common Stock (1700) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 875391 | Indirect |
Footnotes
F1: Acquired as a result of exercising a stock option that was scheduled to expire on 1/2/12. The purchase and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 10/3/11.
F2: Acquired as a result of exercising a stock option that was scheduled to expire on 1/2/12. The purchase and sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the wife of the reporting person on 10/3/11.
More from IONIS PHARMACEUTICALS INC
Regulatory Filings
2026
May 28
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24